Enterococci form a complex, diverse, and very important group of bacteria from the technological and food safety aspect, or from the health-improving aspect as probiotics. Generally, enterococci are considered to be of low pathogenic potential, which is associated mostly with clinical strains. In these strains, production of virulence factors as well as resistance to many antimicrobial drugs could complicate treatment of nosocomial infections. Because there is a lack of information on incidence of these attributes in animal commensal enterococci, we screened 160 strains originating from feces of clinically healthy dogs in Eastern Slovakia (n = 105). The predominant species were Enterococcus faecium (57.5%) followed by Enterococcus faecalis (21.9%), and Enterococcus hirae (17.5%), while Enterococcus casseliflavus (1.9%) and Enterococcus mundtii (1.2%) rarely occurred. Among the tested antibiotics, gentamicin (high level) was the most effective drug against canine enterococci (95% of isolates were sensitive). In contrast, the highest resistance recorded (71.9%) was to teicoplanin. PCR screening showed the highest incidence of virulence genes in E. faecalis species. The most frequently detected were genes encoding adhesins efa Afm and efa Afs and sex pheromone cpd. IS16 gene, a marker specific for hospital strains, appeared in nine E. faecium strains. No strain was positive for DNase activity, 8.8% of the isolated strains showed gelatinase activity, and almost 100% strains produced tyramine. It seems commensal-derived enterococci from dogs could also to some extent be potential reservoir of risk factors for other microbiota or organisms.

Institute of Animal Physiology Slovak Academy of Sciences Šoltésovej 4 6 040 01 Košice Slovakia

Zobrazit více v PubMed

Antimicrob Agents Chemother. 2007 Jun;51(6):2189-91 PubMed

Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):815-25 PubMed

J Vet Intern Med. 2011 Jul-Aug;25(4):856-60 PubMed

Can J Microbiol. 2009 Feb;55(2):215-8 PubMed

J Appl Microbiol. 2001 Dec;91(6):997-1003 PubMed

Folia Microbiol (Praha). 2004;49(6):763-8 PubMed

Curr Protein Pept Sci. 2005 Feb;6(1):77-84 PubMed

J Antimicrob Chemother. 2013 Apr;68(4):731-42 PubMed

Crit Care Clin. 2013 Oct;29(4):841-52 PubMed

Int J Syst Bacteriol. 1997 Apr;47(2):590-2 PubMed

Microbiology (Reading). 2009 Jun;155(Pt 6):1749-1757 PubMed

J Antimicrob Chemother. 2004 Aug;54(2):321-32 PubMed

BMC Infect Dis. 2011 Mar 31;11:80 PubMed

BMC Infect Dis. 2015 Oct 16;15:426 PubMed

Zoonoses Public Health. 2012 Sep;59(6):375-8 PubMed

Int J Food Microbiol. 1999 Dec 1;53(1):33-41 PubMed

Appl Environ Microbiol. 2009 Apr;75(8):2360-5 PubMed

Nat Rev Microbiol. 2012 Mar 16;10(4):266-78 PubMed

Food Microbiol. 2012 May;30(1):132-8 PubMed

J Vet Intern Med. 2015 Jul-Aug;29(4):1045-52 PubMed

New Microbiol. 2015 Jul;38(3):369-78 PubMed

Syst Appl Microbiol. 2003 Mar;26(1):13-22 PubMed

BMC Microbiol. 2013 Dec 10;13:288 PubMed

J Vet Med Sci. 2014 Oct;76(10):1399-402 PubMed

Syst Appl Microbiol. 2011 Dec;34(8):553-60 PubMed

J Appl Microbiol. 2009 Oct;107(4):1269-78 PubMed

Appl Environ Microbiol. 2001 Apr;67(4):1628-35 PubMed

Clin Microbiol Infect. 2011 Apr;17(4):533-8 PubMed

Int J Food Microbiol. 2006 Dec 1;112(3):208-14 PubMed

Some safety aspects of enterococci isolated from Slovak lactic acid dairy product "žinčica"

Evaluation of enterococci for potential probiotic utilization in dogs